176 related articles for article (PubMed ID: 21940908)
1. Reversal of epigenetic silencing of AP-2alpha results in increased zinc uptake in DU-145 and LNCaP prostate cancer cells.
Makhov PB; Golovine KV; Kutikov A; Canter DJ; Rybko VA; Roshchin DA; Matveev VB; Uzzo RG; Kolenko VM
Carcinogenesis; 2011 Dec; 32(12):1773-81. PubMed ID: 21940908
[TBL] [Abstract][Full Text] [Related]
2. hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer.
Franklin RB; Feng P; Milon B; Desouki MM; Singh KK; Kajdacsy-Balla A; Bagasra O; Costello LC
Mol Cancer; 2005 Sep; 4():32. PubMed ID: 16153295
[TBL] [Abstract][Full Text] [Related]
3. Deregulated expression of urokinase and its inhibitor type 1 in prostate cancer cells: role of epigenetic mechanisms.
Hagelgans A; Menschikowski M; Fuessel S; Nacke B; Arneth BM; Wirth MP; Siegert G
Exp Mol Pathol; 2013 Jun; 94(3):458-65. PubMed ID: 23541763
[TBL] [Abstract][Full Text] [Related]
4. AP-2 regulates the transcription of estrogen receptor (ER)-beta by acting through a methylation hotspot of the 0N promoter in prostate cancer cells.
Zhang X; Leung YK; Ho SM
Oncogene; 2007 Nov; 26(52):7346-54. PubMed ID: 17525739
[TBL] [Abstract][Full Text] [Related]
5. Activator protein 2alpha status determines the chemosensitivity of cancer cells: implications in cancer chemotherapy.
Wajapeyee N; Raut CG; Somasundaram K
Cancer Res; 2005 Oct; 65(19):8628-34. PubMed ID: 16204029
[TBL] [Abstract][Full Text] [Related]
6. hZIP1 zinc transporter down-regulation in prostate cancer involves the overexpression of ras responsive element binding protein-1 (RREB-1).
Zou J; Milon BC; Desouki MM; Costello LC; Franklin RB
Prostate; 2011 Oct; 71(14):1518-24. PubMed ID: 21360563
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines.
Sekita N; Suzuki H; Ichikawa T; Kito H; Akakura K; Igarashi T; Nakayama T; Watanabe M; Shiraishi T; Toyota M; Yoshie O; Ito H
Jpn J Cancer Res; 2001 Sep; 92(9):947-51. PubMed ID: 11572762
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of the major zinc uptake protein hZip1 in prostate cancer cells.
Makhov P; Golovine K; Uzzo RG; Wuestefeld T; Scoll BJ; Kolenko VM
Gene; 2009 Feb; 431(1-2):39-46. PubMed ID: 19026724
[TBL] [Abstract][Full Text] [Related]
9. Testis specific Y-like 5: gene expression, methylation and implications for drug sensitivity in prostate carcinoma.
Kumar SR; Bryan JN; Esebua M; Amos-Landgraf J; May TJ
BMC Cancer; 2017 Feb; 17(1):158. PubMed ID: 28235398
[TBL] [Abstract][Full Text] [Related]
10. AP-2alpha induces epigenetic silencing of tumor suppressive genes and microsatellite instability in head and neck squamous cell carcinoma.
Bennett KL; Romigh T; Eng C
PLoS One; 2009 Sep; 4(9):e6931. PubMed ID: 19742317
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer.
Luo W; Karpf AR; Deeb KK; Muindi JR; Morrison CD; Johnson CS; Trump DL
Cancer Res; 2010 Jul; 70(14):5953-62. PubMed ID: 20587525
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic inactivation of the tissue inhibitor of metalloproteinase-2 (TIMP-2) gene in human prostate tumors.
Pulukuri SM; Patibandla S; Patel J; Estes N; Rao JS
Oncogene; 2007 Aug; 26(36):5229-37. PubMed ID: 17325663
[TBL] [Abstract][Full Text] [Related]
13. Progression to metastatic stage in a cellular model of prostate cancer is associated with methylation of the androgen receptor gene and transcriptional suppression of the insulin-like growth factor-I receptor gene.
Schayek H; Bentov I; Sun S; Plymate SR; Werner H
Exp Cell Res; 2010 May; 316(9):1479-88. PubMed ID: 20338164
[TBL] [Abstract][Full Text] [Related]
14. GSTP1 DNA methylation and expression status is indicative of 5-aza-2'-deoxycytidine efficacy in human prostate cancer cells.
Chiam K; Centenera MM; Butler LM; Tilley WD; Bianco-Miotto T
PLoS One; 2011; 6(9):e25634. PubMed ID: 21980513
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of AKAP12 promoter methylation in human prostate cancer using methylation-sensitive high-resolution melting: correlation with Gleason score.
Liu W; Gong J; Hu J; Hu T; Sun Y; Du J; Sun C; Guan M; Jiang H; Lu Y
Urology; 2011 Apr; 77(4):1006.e1-7. PubMed ID: 21310466
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation as a novel regulator of ANO1 expression and function in prostate cancer bone metastasis.
Shin Y; Kim S; An W
Sci Rep; 2024 May; 14(1):11595. PubMed ID: 38773164
[TBL] [Abstract][Full Text] [Related]
17. Insensitivity to transforming growth factor-beta results from promoter methylation of cognate receptors in human prostate cancer cells (LNCaP).
Zhang Q; Rubenstein JN; Jang TL; Pins M; Javonovic B; Yang X; Kim SJ; Park I; Lee C
Mol Endocrinol; 2005 Sep; 19(9):2390-9. PubMed ID: 15905358
[TBL] [Abstract][Full Text] [Related]
18. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
[TBL] [Abstract][Full Text] [Related]
19. Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer.
Leiblich A; Cross SS; Catto JW; Phillips JT; Leung HY; Hamdy FC; Rehman I
Oncogene; 2006 May; 25(20):2953-60. PubMed ID: 16547507
[TBL] [Abstract][Full Text] [Related]
20. Methylation mediated silencing of TMS1/ASC gene in prostate cancer.
Das PM; Ramachandran K; Vanwert J; Ferdinand L; Gopisetty G; Reis IM; Singal R
Mol Cancer; 2006 Jul; 5():28. PubMed ID: 16848908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
